BioImpact Capital LLC, 10% Owner at Cullinan Oncology, Inc. (CGEM), sold 20,637 shares at $29.17 ($602K) on 2021-09-14, disclosed to the SEC on 2021-09-16.
Scheduled sale ($602k) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.17 | 7,106 | $207K | 34.4% |
| 2 | $29.17 | 7,106 | $207K | 34.4% |
| 3 | $29.16 | 6,425 | $187K | 31.1% |
| Total | $29.17 avg | 20,637 | $602K | 100% |
| Filing → |
| CGEM | SELL | 2021-09-20 | $182K | — | Filing → |
| CGEM | SELL | 2021-09-13 | $1.4M | — | Filing → |
| ITOS | SELL | 2021-09-13 | $5.5M | — | Filing → |